ADMA: an emerging cardiovascular risk factor
- PMID: 16444862
- DOI: 10.1177/1358836X0501000101
ADMA: an emerging cardiovascular risk factor
Similar articles
-
Proceedings of the 2nd International Symposium on ADMA -- An Emerging Cardiovascular Risk Factor, November 6, 2004, New Orleans, Louisiana, USA.Vasc Med. 2005 Jul;10 Suppl 1:S1-102. Vasc Med. 2005. PMID: 16927465 No abstract available.
-
Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule.Med Sci Monit. 2009 Apr;15(4):RA91-101. Med Sci Monit. 2009. PMID: 19333216 Review.
-
Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of L-arginine on its metabolism.Mol Genet Metab. 2007 Aug;91(4):309-17; discussion 308. doi: 10.1016/j.ymgme.2007.04.017. Epub 2007 Jun 7. Mol Genet Metab. 2007. PMID: 17560156 Review.
-
When the endothelium cannot say 'NO' anymore. ADMA, an endogenous inhibitor of NO synthase, promotes cardiovascular disease.Eur Heart J. 2003 Nov;24(21):1901-2. doi: 10.1016/j.ehj.2003.08.010. Eur Heart J. 2003. PMID: 14585247 No abstract available.
-
Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway.Arterioscler Thromb Vasc Biol. 2004 Jun;24(6):1023-30. doi: 10.1161/01.ATV.0000128897.54893.26. Epub 2004 Apr 22. Arterioscler Thromb Vasc Biol. 2004. PMID: 15105281 Review.
Cited by
-
The Second Life of Methylarginines as Cardiovascular Targets.Int J Mol Sci. 2019 Sep 17;20(18):4592. doi: 10.3390/ijms20184592. Int J Mol Sci. 2019. PMID: 31533264 Free PMC article. Review.
-
Reference intervals for plasma L-arginine and the L-arginine:asymmetric dimethylarginine ratio in the Framingham Offspring Cohort.J Nutr. 2011 Dec;141(12):2186-90. doi: 10.3945/jn.111.148197. Epub 2011 Oct 26. J Nutr. 2011. PMID: 22031661 Free PMC article.
-
Crystal structure of the plant epigenetic protein arginine methyltransferase 10.J Mol Biol. 2011 Nov 18;414(1):106-22. doi: 10.1016/j.jmb.2011.09.040. Epub 2011 Oct 1. J Mol Biol. 2011. PMID: 21986201 Free PMC article.
-
Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study.PLoS One. 2018 May 22;13(5):e0197148. doi: 10.1371/journal.pone.0197148. eCollection 2018. PLoS One. 2018. PMID: 29787597 Free PMC article.
-
Homoarginine and methylarginines independently predict long-term outcome in patients presenting with suspicion of venous thromboembolism.Sci Rep. 2021 May 5;11(1):9569. doi: 10.1038/s41598-021-88986-y. Sci Rep. 2021. PMID: 33953241 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources